...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Veterinary Applications?

So.....lymphoma is also a common and heartbreaking disease in canines.

Zen 3694 and 3365, as well as CPI 0610 and Some others.... OTX 015, I-BET762, etc. have shown success with lymphoma in animal models, but I cannot find any articles specifically on whether there have been any canine clinical trials for ANY epigenetic treatment for lymphoma. (or anything at all, actually)

There seems to be a new-ish chemo drug called Tanovea-CA1...I could find no studies combining Tanovea or CHOP treatment with epigenetic solutions either. 

I am wondering whether anyone out there might be able to offer any information on progress toward veterinary epigenetic treatments? 

Those would also have a HUGE market.  It would seem animal models for development of human treatment must also provide valuable information for veterinary medicine. But I find no veterinary follow-up. Maybe I am just looking in the wrong places? 

Any information that anyone has would be appreciated.

Share
New Message
Please login to post a reply